Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial

Patricia J. A. M. Brouwers*, Erik van Werkhoven, Harry Bartelink, Alain Fourquet, Claire Lemanski, Judith van Loon, John H. Maduro, Nicola S. Russell, Luc J. E. E. Scheijmans, Dominic A. X. Schinagl, Antonia H. Westenberg, Philip Poortmans, Liesbeth J. Boersma, Young Boost Trial Res Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)434-441
Number of pages8
JournalRadiotherapy and Oncology
Volume128
Issue number3
DOIs
Publication statusPublished - Sep 2018

Keywords

  • Breast conserving therapy
  • Cosmetic outcome
  • Fibrosis
  • Young patients
  • Young boost trial
  • SIMULTANEOUS INTEGRATED BOOST
  • INTENSITY-MODULATED RADIOTHERAPY
  • NO BOOST
  • RADIATION-THERAPY
  • TUMOR BED
  • CONFORMAL RADIOTHERAPY
  • CONSERVATIVE TREATMENT
  • RANDOMIZED-TRIALS
  • EORTC BOOST
  • FOLLOW-UP

Cite this

Brouwers, P. J. A. M., van Werkhoven, E., Bartelink, H., Fourquet, A., Lemanski, C., van Loon, J., Maduro, J. H., Russell, N. S., Scheijmans, L. J. E. E., Schinagl, D. A. X., Westenberg, A. H., Poortmans, P., Boersma, L. J., & Young Boost Trial Res Grp (2018). Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial. Radiotherapy and Oncology, 128(3), 434-441. https://doi.org/10.1016/j.radonc.2018.06.020